首页 | 本学科首页   官方微博 | 高级检索  
检索        

经尿道膀胱肿瘤电切术联合膀胱灌注治疗膀胱肿瘤的临床观察
引用本文:张成辉,刘海梅.经尿道膀胱肿瘤电切术联合膀胱灌注治疗膀胱肿瘤的临床观察[J].湖南师范大学学报(医学版),2017,14(5).
作者姓名:张成辉  刘海梅
作者单位:1. 青海省交通医院泌尿外科,西宁,810000;2. 青海省藏医院外科,西宁,810007
摘    要:目的:探讨经尿道膀胱肿瘤电切术联合膀胱灌注在治疗膀胱肿瘤中的临床效果.方法:选择我院2012年2月~2016年2月期间经尿道膀胱肿瘤电切术治疗膀胱肿瘤患者65例,术后定期给予丝裂霉素C、噻替哌、吡柔比星等药物膀胱腔内灌注化疗,并定期随访,观察患者术后复发及不良反应等情况.结果:本组65例患者经尿道膀胱肿瘤电切术后膀胱肿瘤复发率36.7%、不良反应发生率33.8%,且复发率随着膀胱肿瘤病理分级的增高而逐渐增高,相互之间差异具有统计学意义;电切术后联合膀胱灌注治疗,复发率16.7%、不良反应发生率15.4%,与单纯的电切术治疗相比,复发率和不良反应发生率差异均具有统计学意义;三种不同灌注药物治疗患者的复发率及不良反应发生率差异均无统计学意义.结论:采用经尿道膀胱肿瘤电切术联合膀胱灌注治疗膀胱肿瘤,二者相得益彰,可以有效降低术后膀胱肿瘤的复发率,减少不良反应,提高治疗效果,值得临床进一步推广与应用.

关 键 词:膀胱肿瘤  膀胱灌注  经尿道电切术  吡柔比星

Clinical Observation of Transurethral Resection of Bladder Tumor Combined with Bladder Instillation for Bladder Cancer
Zhang Cheng-hui,Liu Hai-mei.Clinical Observation of Transurethral Resection of Bladder Tumor Combined with Bladder Instillation for Bladder Cancer[J].Journal of Hunan Normal University(Medical Science),2017,14(5).
Authors:Zhang Cheng-hui  Liu Hai-mei
Abstract:Objective To investigate the clinical effect of transurethral resection of bladder tumor combined with bladder instillation for bladder cancer.Methods 65 cases of bladder cancer patients in our hospital were selected from February 2012 to February 2016. All patients were treated with transurethral resection of bladder tumor. After the operation, regularly given mito-mycin C, thiotepa, pirarubicin intravesical instillation of chemotherapy drugs, and regular follow-up to observe the postoperative recurrence and adverse reactions.Results The group of 65 patients by transurethral resection of bladder tumor postoperative bladder tumor recurrence rate of 36.7% and adverse reaction incidence rate of 33.8% restriction, and the recurrence rate with pathological grading of bladder cancer increased gradually increased, the difference between each other with statistical signifi-cance. After transurethral resection of bladder tumor combined with bladder instillation, the recurrence rate was 16.7% and the incidence of adverse reactions was 15.4%. There was a significant difference between recurrence rate and adverse reaction rate. There was no significant difference in the recurrence rate and incidence of adverse reactions between the three different types of drug infusion.Conclusion Using transurethral resection of bladder tumor combined with bladder instillation for bladder cancer, the two complement each other, can effectively reduce the recurrence rate of bladder cancer after operation, reduce adverse re-action, improve the therapeutic effect. It is worthy of further popularization and application.
Keywords:bladder cancer  bladder instillation  transurethral resection  pirarubicin
本文献已被 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号